Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion By: CNBC.com News January 08, 2024 at 09:09 AM EST The deal, which was announced on the first day of the annual JPMorgan Healthcare Conference, makes J&J the latest drugmaker to bet on ADCs. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion By: CNBC.com News January 08, 2024 at 09:09 AM EST The deal, which was announced on the first day of the annual JPMorgan Healthcare Conference, makes J&J the latest drugmaker to bet on ADCs. Read More >>